Skip to main content

Table 1 Demographic and clinical characteristics of the study participants

From: Respiratory microbes detected in hospitalized adults with acute respiratory infections: associations between influenza A(H1N1)pdm09 virus and intensive care unit admission or fatal outcome in Vietnam (2015–2017)

Selected variables All (n = 269) ICU (n = 69) Non-ICU (n = 200) Dead (n = 25) Alive (n = 244)
Sex (Male, %) 155 (57.6) 35 (50.7) 120 (60.0) 16 (64.0) 139 (57.0)
Age; Median (IQR); years 51 (33–65) 54 (40–67) 50 (31–64) 56 (47–67) 50 (31–65)
Duration from onset to sampling; Median (IQR); days 5 (3–7) 5 (4–8) 5 (3–7) 6 (4–9) 5 (3–7)
Dead patients 25 (9.3) 23 (33.3) 2 (1.0)   
Comorbidities or conditions 162 (60.2) 45 (65.2) 117 (58.5) 19 (76.0) 143 (58.6)
 Lung disease 34 (12.6) 6 (8.7) 28 (14.0) 1 (4.0) 33 (13.5)
 Hypertension 27 (10.0) 10 (14.5) 17 (8.5) 3 (12.0) 24 (9.8)
 Diabetes mellitus 24 (8.9) 12 (17.4) 12 (6.0) 4 (16.0) 20 (8.2)
 Liver disease 24 (8.9) 5 (7.2) 19 (9.5) 4 (16.0) 20 (8.2)
 Cardiovascular disease 22 (8.2) 10 (14.5) 12 (6.0) 3 (12.0) 19 (7.8)
 Pregnancy 19 (7.1) 3 (4.3) 16 (8.0) 0 (0) 19 (7.8)
 Kidney disease 19 (7.1) 6 (8.7) 13 (6.5) 1 (4.0) 18 (7.4)
 Collagen disease 11 (4.1) 5 (7.2) 6 (3.0) 3 (12.0) 8 (3.3)
 Cancer 9 (3.3) 3 (4.3) 6 (3.0) 0 (0) 9 (3.7)
 Tuberculosis 6 (2.2) 2 (2.9) 4 (2.0) 1 (4.0) 5 (2.0)
 HBV/HCV 6 (2.2) 1 (1.4) 5 (2.5) 1 (4.0) 5 (2.0)
 Hematological disease*1 5 (1.9) 5 (7.2) 0 (0) 4 (16.0) 1 (0.4)
 Bronchial asthma 4 (1.5) 3 (4.3) 1 (0.5) 0 (0) 4 (1.6)
 Immunosuppressive agent usage*2 4 (1.5) 4 (5.8) 0 (0) 4 (16.0) 0 (0)
 Others 16 (5.9) 4 (5.8) 12 (6.0) 2 (8.0) 14 (5.7)
  1. Data are presented as numbers (%). IQR interquartile range. *1: significant differences after Bonferroni correction between ICU and non-ICU patients (Fisher’s exact test, corrected significance level p = 0.0033). *1, *2: significant differences after Bonferroni correction between Dead and Alive patients. (Fisher’s exact test, corrected significance level p = 0.0033). ICU intensive care unit, HBV/HCV hepatitis B or hepatitis C